CLINICAL_TRIALS
trial_result
· 2011-07-18
Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children [Phase 3]
Summary
A Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine in healthy children has completed and results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pneumococcal Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2011-07-18